2018 Bioelectronic Medicine Forum

March 22, 2018

Millenium Broadway, New York, NY

Tentative Agenda

8:00-8:30

Registration and Coffee

8:30-8:45

Overview of the Bioelectronic Medicine Industry

James Cavuoto, Editor and Publisher, Neurotech Reports
Neurotech Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections.
8:45-10:00

Keynotes: Bioelectronic Medicine's Beginnings

Kristoffer Famm, Ph.D., President, Galvani Bioelectronics
Gene Civillico, Ph.D., Program Manager, NIH SPARC Program
Eric Van Gieson, Ph.D., Program Manager, DARPA Biological Technologies Office
This keynote session features leaders of three key organizations that played a major role in the founding of the bioelectronic medicine industry, including the heads of two government funding programs for bioelectronic medicine and the president of the flagship commercial firm in the space. Dr. Famm will reflect on the industry's growth in the first five years. Dr. Civillico will describe the NIH's SPARC program, while Dr. van Gieson will discuss DARPA's ElectRx program.
10:00-10:30

Refreshment Break

10:30-11:15

Entrepreneur Panel I

Jennifer French, Senior Editor, Neurotech Reports, Moderator
Milton Morris, Ph.D., President and CEO, NeuSpera Medical
Nader Yaghoubi, M.D., Ph.D., President and CEO, PathMaker Neurosystems, Inc.
Jim Ross, Ph.D., Co-Founder and CTO, Axion Biosystems
Presentations from executives of emerging bioelectronic medicine firms.
11:15-12:00

Investment in Bioelectronic Medicine

James Cavuoto, Editor and Publisher, Neurotech Reports
Imran Eba, Partner, Action Potential Venture Capital
Andrew ElBardissi, M.D., Principal, Deerfield Management
Evan Norton, Divisional Vice President, Abbott Ventures
David Turkaly, Research Analyst, JMP Securities
In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine.
12:00-1:30

Luncheon

Next-Generation Psychiatry
Helen Mayberg, M.D., Director, Mount Sinai Center for Advanced Circuit Therapeutics
1:30-2:15

Pharma's Future in Bioelectronic Medicine

Imran Eba, Partner, Action Potential Venture Capital, Moderator
Kristoffer Famm, Ph.D., President, Galvani Bioelectronics
Kadir Kadhiresan, Ph.D., Vice President,Venture Investments, Johnson & Johnson Development Corp.
In this session, executives with experience in the biopharm and neuromodulation device industries will offer their views on the role that bioelectronic medicine will play in the pharmaceutical industry.
2:15-3:00

Entrepreneur Panel II

James Cavuoto, Editor, Neurotech Reports, Moderator
Tina Chang, Director of International Business, GiMer Medical
Joern Rickert, Ph.D., CEO, CorTec GmbH
Ana Maiques, CEO, Neuroelectrics
Presentations from executives of emerging bioelectronic medicine firms.
3:00-3:30

Refreshment Break

3:30-4:15

Entrepreneur Panel III

James Cavuoto, Editor, Neurotech Reports, Moderator
Nadim Yared, President and CEO, CVRx, Inc.
Allen Braswell, CEO, Magneceutical Health
Chris Czura, Ph.D., Co-founder and Chief Scientific Officer, Sanguistat, Inc.
Presentations from executives of emerging bioelectronic medicine firms.
4:15-5:00

Regulatory and Reimbursement Issues

Jeremy Koff, Senior Contributing Editor, Neurotech Reports, Moderator
Edward Black, President, Reimbursement Strategies LLC
Peter Staats, M.D., Chief Medical Officer, electroCore LLC
Chad Gibson, Managing Partner, CMD Medtech
Startup and established bioelectronic medicine firms face a variety of regulatory and reimbursement issues on the way to commercialization. In this closing session, we'll explore key considerations in designing clinical trials, obtaining FDA approval, and getting reimbursement from payors.
5:00-7:00

Cocktail Reception

 
 

 

site design by shalatdesign | shalat.com